Bile duct ligation of C57BL/6 mice as a model of hepatic encephalopathy

다국어 초록 (Multilingual Abstract)

Background: Bile duct ligation (BDL) has been used for experimental research on hepatic encephalopathy (HE) caused by chronic liver disease. However, little research has been done on a BDL model in C57BL/6 mouse. Therefore, we evaluated the suitability of a BDL model in C57BL/6 mouse for the study of HE and determined which behavioral tests are appropriate for the identification of HE in this model.
Methods: Twelve to fourteen-week-old male C57BL/6 mice were randomly assigned to either sham group or BDL group. Histological changes in liver were confirmed by hematoxylin/ eosin and Masson’s trichrome staining. Liver function alterations were detected by alanine aminotransferase (ALT) and ammonia levels. To identify behavioral changes, open field, elevated plus maze, novel object recognition, and passive avoidance tests were performed.
Results: Inflammatory liver injury and fibrosis were observed 14 days after BDL. ALT and ammonia levels were significantly higher in BDL group than in sham group. There were no differences in general locomotor activity or anxiety between the groups. No difference was observed between these two groups in the novel object recognition test, but BDL group showed significant learning/memory impairment in the passive avoidance test compared to sham group.
Conclusions: Fourteen days of BDL in 12–14-week-old male C57BL/6 mice is a clinically relevant model for HE, as these mice have liver fibrosis with impaired liver function, hyperammonemia, and learning/memory impairment. Passive avoidance can be used as the major behavioral test in this model of HE.

참고문헌 (Reference)

1 Sang Soo Lee, "Type and cause of liver disease in Korea: single-center experience, 2005-2010" 대한간학회 18 (18): 309-315, 2012

2 Farjam M, "Thioacetamide-induced acute hepatic encephalopathy in rat : behavioral, biochemical and histological changes" 14 : 164-170, 2012

3 Kerfoot SM, "TNF-alpha-secreting monocytes are recruited into the brain of cholestatic mice" 43 : 154-162, 2006

4 Rogers AB, "Stress of strains : inbred mice in liver research" 19 : 61-67, 2018

5 김중선, "Strain-dependent Differences of Locomotor Activity and Hippocampus-dependent Learning and Memory in Mice" 한국독성학회 24 (24): 183-188, 2008

6 Soto-Gutiérrez A, "Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes" 24 : 1412-1419, 2006

7 Zarrindast MR, "Possible interaction between opioidergic and cholinergic systems of CA1 in cholestasis-induced amnesia in mice" 228 : 116-124, 2012

8 Lueptow LM, "Novel object recognition test for the investigation of learning and memory in mice" (126) : e55718-, 2017

9 McMillin M, "Neuronal CCL2 is upregulated during hepatic encephalopathy and contributes to microglia activation and neurological decline" 11 : 121-, 2014

10 Chastre A, "Lipopolysaccharide precipitates hepatic encephalopathy and increases blood-brain barrier permeability in mice with acute liver failure" 34 : 353-361, 2014

11 Tag CG, "Induction of experimental obstructive cholestasis in mice" 49 (49): 70-80, 2015

12 Jayakumar AR, "Hyperammonemia in hepatic encephalopathy" 8 : 272-280, 2018

13 Ilic S, "High hepatotoxic dose of paracetamol produces generalized convulsions and brain damage in rats. A counteraction with the stable gastric pentadecapeptide BPC 157 (PL 14736)" 61 : 241-250, 2010

14 Vilstrup H, "Hepatic encephalopathy in chronic liver disease : 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver" 60 : 715-735, 2014

15 Rahimi RS, "Hepatic encephalopathy : pharmacological therapies targeting ammonia" 36 : 48-55, 2016

16 Nasehi M, "Function of opioidergic and dopaminergic antagonists on both spatial and object novelty detection deficits induced in rodent model of hepatic encephalopathy" 313 : 58-66, 2016

17 Zwirner K, "Extracellular brain ammonia levels in association with arterial ammonia, intracranial pressure and the use of albumin dialysis devices in pigs with acute liver failure" 25 : 407-412, 2010

18 Butterworth RF, "Experimental models of hepatic encephalopathy : ISHEN guidelines" 29 : 783-788, 2009

19 Jackson SJ, "Does age matter? The impact of rodent age on study outcomes" 51 : 160-169, 2017

20 Basu PP, "Clinical and neurologic manifestation of minimal hepatic encephalopathy and overt hepatic encephalopathy" 19 : 461-472, 2015

21 D’Mello C, "Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation" 29 : 2089-2102, 2009

22 Cheon SY, "Cellpenetrating interactomic inhibition of nuclear factor-kappa B in a mouse model of postoperative cognitive dysfunction" 7 : 13482-, 2017

23 Magen I, "Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation" 51 : 528-534, 2009

24 Magen I, "Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation" 159 : 950-957, 2010

25 Pacheco GS, "Brain creatine kinase activity is inhibited after hepatic failure induced by carbon tetrachloride or acetaminophen" 24 : 383-394, 2009

26 Tag CG, "Bile duct ligation in mice : induction of inflammatory liver injury and fibrosis by obstructive cholestasis" (96) : e52438-, 2015

27 Starkel P, "Animal models for the study of hepatic fibrosis" 25 : 319-333, 2011

28 Gentile S, "A randomized controlled trial of acarbose in hepatic encephalopathy" 3 : 184-191, 2005

29 Sousa N, "A hitchhiker’s guide to behavioral analysis in laboratory rodents" 5 (5): 5-24, 2006

30 Wolf A, "A comprehensive behavioral test battery to assess learning and memory in 129S6/Tg2576 mice" 11 : e0147733-, 2016